Published on: 25 Feb, 2026 07:30

Markets are set for a flat-to-mildly positive open on February 25, 2026, with GIFT Nifty holding steady amid subdued pre-market brokerage activity. While fresh fundamental calls remain limited, technical cues highlight selective opportunities in healthcare, and easing volatility suggests consolidation ahead of further cues from global trade and domestic earnings.

As of 7:30 AM IST on February 25, 2026 (a regular trading day with no NSE/BSE holiday), fresh fundamental recommendations from major domestic and global brokerages remain limited. Most morning notes and target updates typically emerge closer to or after market open, resulting in a sparse dataset for this automated pre-market snapshot. Searches across ET Markets, Moneycontrol, brokerage sites, and official X handles yielded no new buy/sell/hold ratings or target revisions explicitly timestamped to February 25 from sources like Motilal Oswal, ICICI Securities, HDFC Securities, Kotak, or global names (Jefferies, Goldman Sachs, etc.).

Pre-market cues point to a flat-to-mildly positive open. Gift Nifty traded in the 25,653–25,684 range around 7:00–7:30 AM IST, suggesting Nifty could open near or slightly above its February 24 close of 25,424.65 (down 1.12% or 288 points on expiry-related selling). India VIX eased marginally to 14.15, indicating moderated but still-present volatility amid uncertain global cues. No major overnight US or Asian moves dominated headlines in early scans.

Top themes to watch: Continued consolidation in benchmarks and stock-specific momentum in healthcare amid broader range-bound action. The sole standout fresh call identified is a technical buy on KIMS. Investors should monitor for intraday brokerage updates, as the situation can evolve rapidly post-open. (Word count note: This report prioritizes verified same-day issuances only.)

Section 1: Index Outlook Nifty 50 and Sensex are in a consolidation phase following recent expiry volatility. Analysts highlight a tight 8-session range on Nifty, with no decisive breakout yet.

Index Outlook Target/Range Key Driver Source
Nifty 50 Neutral/Bullish bias if support holds 25,350–25,900 Post-expiry consolidation; VIX at 14.15 ET Markets (Feb 25, 06:11 AM IST)
Sensex Aligned with Nifty 82,000–84,000 (implied) Global uncertainty, domestic range-bound action Derived from Nifty cues
Bank Nifty / Sectoral Not specifically updated Monitor for banking rotation No fresh sector calls today N/A

Key drivers: As long as Nifty holds above 25,300 decisively, a meaningful bounce remains possible. Long positions can be considered with strict stops below that level. Volatility is expected to stay elevated due to global uncertainties. No fresh sectoral index targets (e.g., Bank Nifty, IT, Pharma) were issued today by scanned sources.

Section 2: Sector-Wise Stock Picks Fresh calls are extremely limited at this pre-open hour. No new fundamental Buy/Accumulate/Sell ratings with price targets from primary brokerages were published for individual stocks on February 25.

Healthcare

  • Krishna Institute of Medical Sciences (KIMS) – Buy (current ~₹733.40) Rationale: Short-term bullish momentum confirmed. Stock has surged >5% week-to-date from strong support at the 200-DMA (₹688). Bullish crossover with 21-DMA above 55-DMA adds conviction. Source: The Hindu BusinessLine live market update (timestamped ~06:50 AM IST, Feb 25, 2026). No specific upside target provided in the note.

Other sectors (Metals, Pharma, FMCG, Banking): Technical trading ideas for stocks including JSW Steel, Lupin, Colgate-Palmolive, Torrent Pharma, and Karur Vysya Bank appear in early Moneycontrol coverage for February 25, focusing on short-term setups (buy/sell with targets and stops). However, full details were not extractable in real-time scans; these are primarily technical rather than brokerage fundamental calls and should be cross-verified post-open. No upside % or rationales tied to earnings/FY26 projections were available today.

Mid/small-cap or derivative-specific ideas (e.g., from ICICI Direct’s prior-day derivatives view) remain open but were not refreshed for today. Overall volume of fresh picks: <5 unique, all technical in nature.

(No numerical bar chart generated due to insufficient same-day target data for aggregation.)

Section 3: Global & Thematic Insights Global cues remain uncertain with no dominant overnight drivers highlighted in Indian pre-market coverage. US markets (prior session) and early Asian trades showed mixed sentiment, feeding into the flat Gift Nifty. No India-specific thematic calls (e.g., midcaps, defensives, or capex themes) emerged from global desks like Macquarie, CLSA, or UBS on February 25.

Regulatory/BSE-NSE front: No notable corporate announcements or block-deal implications flagged as analyst-relevant in early scans. IPO-related activity (e.g., ongoing or closing allotments) continues in the background but carries no direct recommendation impact today.

Conclusion & Disclaimer Overall sentiment at market open: Neutral with cautious bullish bias on key supports holding. Focus remains on Nifty’s 25,300–25,900 range and stock-specific moves in healthcare. Actionable takeaway: Monitor KIMS for continuation of momentum and watch for intraday breakout in Nifty above recent highs. With limited fresh calls at 7:30 AM IST, traders should await full brokerage morning notes and earnings-season updates for conviction trades.

This is an aggregated informational snapshot compiled from public sources for reference only. It does not constitute investment advice, buy/sell recommendations, or a guarantee of performance. Markets can move rapidly—consult a SEBI-registered advisor and conduct your own due diligence. Past performance is not indicative of future results. Data current as of ~7:30–8:00 AM IST on February 25, 2026; updates may supersede this report.

Sources & Citations

 


Pre-Market & Index Outlook Sources

2. Fresh Stock Recommendations / Technical Picks (Timestamped February 25)

3. Stocks to Watch / Event-Driven Coverage (February 25)

Top Performing Funds for You
Top Performing Equity Funds Top Performing Debt Funds Top Performing Hybrid Funds


Top Performing Mutual Funds